Results 61 to 70 of about 2,021,559 (378)

Relação entre fração de ejeção cardíaca e pressão arterial em pacientes coronariopatas

open access: yesRev Rene, 2017
Objective: to analyze the existence of a relationship between cardiac ejection fraction during hospitalization with blood pressure values obtained before and during hospitalization in patients hospitalized for coronary disease.
Nila Larisse Silva de Albuquerque   +4 more
doaj   +1 more source

Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status [PDF]

open access: yes, 2019
Aims: Heart failure is a clinical syndrome characterized by subclinical systemic inflammation and immune system activation associated with iron deficiency.
Corrao S.   +10 more
core   +1 more source

Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.

open access: yesJAMA cardiology, 2021
Importance Heart failure (HF) with preserved ejection fraction (HFpEF) is common, is frequently associated with ventricular wall thickening, and has no effective therapy.
O. AbouEzzeddine   +14 more
semanticscholar   +1 more source

Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction [PDF]

open access: yesCirculation: Heart Failure, 2012
Background— Heart failure (HF) can occur in patients with preserved (HFpEF, EF≥50%) or reduced (HFrEF, EF<50%) ejection fraction (EF), but changes in EF after HF diagnosis are not well described. Methods and Results— Among a community cohort of incident HF patients
Véronique L. Roger   +4 more
openaire   +3 more sources

Rescue of Pressure Overload-Induced Heart Failure by Estrogen Therapy. [PDF]

open access: yes, 2016
BackgroundEstrogen pretreatment has been shown to attenuate the development of heart hypertrophy, but it is not known whether estrogen could also rescue heart failure (HF).
Bopassa, Jean C   +12 more
core   +1 more source

Nicotinamide for the treatment of heart failure with preserved ejection fraction

open access: yesScience Translational Medicine, 2021
The NAD+ precursor nicotinamide improves diastolic dysfunction caused by aging, hypertension, or metabolic syndrome in rodents. Diet and diastolic dysfunction Increasing nicotinamide adenine dinucleotide (NAD+) can mimic some of the benefits of caloric ...
M. Abdellatif   +43 more
semanticscholar   +1 more source

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction

open access: yesArquivos Brasileiros de Cardiologia, 2015
Background: The prevalence and clinical outcomes of heart failure with preserved left ventricular ejection fraction after acute myocardial infarction have not been well elucidated. Objective: To analyze the prevalence of heart failure with preserved left
Lucas Antonelli   +9 more
doaj   +1 more source

Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Many patients with heart failure (HF) experience changes in left ventricular ejection fraction (LVEF) during follow‐up. We sought to evaluate the predictors and outcomes of different HF phenotypes according to longitudinal changes in EF ...
Jin Joo Park   +5 more
doaj   +1 more source

Contemporary characteristics and outcomes in chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy [PDF]

open access: yes, 2017
Background: Chagas’ disease is an important cause of cardiomyopathy in Latin America. We aimed to compare clinical characteristics and outcomes in patients with heart failure (HF) with reduced ejection fraction caused by Chagas’ disease, with other ...
Claudio R. Gimpelewicz   +17 more
core   +3 more sources

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction

open access: yesCirculation, 2021
Supplemental Digital Content is available in the text. Background: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure with preserved ejection fraction, but additional data are needed
M. Packer   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy